fda

Who benefits most from FDA’s ‘accelerated’ drug approvals? Patients or drugmakers?

Abigail Fagan, Mark Kaufman |
Increasing reliance on this and other means of moving drugs quickly to market have many critics worried, given that drugmakers ...